Saratoga notes AI agents and generative AI pose competitive threats to its SaaS portfolio companies.
“A number of our portfolio companies are in the Software-as-a-Service (“SAAS”) industry and such companies are subject to additional risks that are unique to the SAAS industry. The rapid emergence of AI-first companies and generative AI tools poses significant competitive threats to traditional SAAS business models. In January 2026, AI companies such as OpenAI and Anthropic announced HIPAA-compliant life sciences and healthcare tools that directly compete with established SAAS vendors, demonstrating how AI-native companies are increasingly launching vertical-specific applications that challenge incumbents. It is possible that AI agents and autonomous AI systems could displace traditional business applications. Our portfolio companies may face margin pressure, customer churn, and declining recurring revenue if they fail to effectively integrate AI capabilities, differentiate their offerings from AI-native competitors, or adapt their technology platforms to meet evolving customer expectations for AI-powered functionality. The shifting technology landscape may require significant investment in research and development, product reimagination, and go-to-market strategy changes that our portfolio companies may be unable or unwilling to undertake.”